HomeRSLS • NASDAQ
add
ReShape Lifesciences Inc
Previous close
$4.25
Day range
$4.11 - $4.29
Year range
$4.03 - $414.99
Market cap
3.08M USD
Avg Volume
2.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.11M | -42.75% |
Operating expense | 2.52M | -25.33% |
Net income | 1.47M | 167.21% |
Net profit margin | 132.43 | 217.39% |
Earnings per share | — | — |
EBITDA | -1.84M | 16.74% |
Effective tax rate | 0.47% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.52M | 5.72% |
Total assets | 6.48M | -21.24% |
Total liabilities | 5.25M | 42.09% |
Total equity | 1.23M | — |
Shares outstanding | 738.28K | — |
Price to book | 0.46 | — |
Return on assets | -81.54% | — |
Return on capital | -443.35% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.47M | 167.21% |
Cash from operations | -2.12M | -2.27% |
Cash from investing | — | — |
Cash from financing | 3.95M | — |
Net change in cash | 1.82M | 187.60% |
Free cash flow | -1.09M | 11.99% |
About
Founded
2002
Website
Employees
18
